Details for New Drug Application (NDA): 219689
✉ Email this page to a colleague
The generic ingredient in GUANFACINE HYDROCHLORIDE is guanfacine hydrochloride. There are seven drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
Summary for 219689
| Tradename: | GUANFACINE HYDROCHLORIDE |
| Applicant: | Rubicon Research |
| Ingredient: | guanfacine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 219689
| Mechanism of Action | Adrenergic alpha2-Agonists |
Medical Subject Heading (MeSH) Categories for 219689
Suppliers and Packaging for NDA: 219689
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 219689 | ANDA | Advagen Pharma Limited | 72888-224 | 72888-224-00 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-00) |
| GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 219689 | ANDA | Advagen Pharma Limited | 72888-224 | 72888-224-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-224-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Apr 15, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 2MG BASE | ||||
| Approval Date: | Apr 15, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 3MG BASE | ||||
| Approval Date: | Apr 15, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
